Cystic fibrosis drug added to Ont. drug benefit

The government has officially added a costly medication to the Ontario drug benefit formulary.

Kalydeco, a treatment for cystic fibrosis that some patients need to survive, costs $300,000 a year.

Madi Vanstone, 12, has a form of cystic fibrosis that responds to the drug. She petitioned the government to cover the cost that was quickly putting her family into debt. After two personal pleas to the legislature, a deal has been reached.

Patients who qualify will need a special request from their doctor for coverage.